This contract opportunity involves the supply, preparation, installation, and commissioning of two digital remote controls. These devices are intended for use at the University Hospital Insular de Gran Canaria and the Telde CAE, both part of the Insular Materno Infantil University Hospital Complex i
Tender closed on 21 Jul 2025. Awaiting award.
No single supplier dominates the field.
In healthcare medical, MANAGEMENT DIRECTORATE OF THE INSULAR MATERNAL AND CHILD UNIVERSITY HOSPITAL COMPLEX has awarded 4 contracts to 4 suppliers.
Across healthcare medical, the most active winners are URTICA SP Z O O, SALUS INTERNATIONAL SP Z O O, URTICA SP Z OO — the field to beat, or your route in as a partner.
This contract involves the supply of laboratory reagents and the provision of equipment for the Insular Materno Infantil University Hospital Complex. The purpose is to support genetic testing services as part of the Common Services Portfolio of the National Health System, under the Personalized Medi
This contract involves the procurement of two specific pharmaceutical products: Infliximab and Selumetinib Sulfato. These medications are essential for the Insular-Materno Infantil University Hospital Complex in Gran Canaria, aimed at meeting the hospital's supply needs to treat, alleviate, or cure
This contract involves the procurement of two specific pharmaceutical products, Momelotinib and Sotorasib, to meet the supply needs of the Insular-Materno Infantil University Hospital Complex in Gran Canaria, Spain. The total value of the contract is approximately €200,086.08. Suppliers are invited
NHS Scotland is seeking suppliers of generic and biosimilar cancer medicines to improve patient access and optimize healthcare costs.
Royal Borough of Greenwich is commissioning a School Health and Wellbeing Service to deliver preventative health and early intervention support for children and young people aged 5-19 years across the borough, with contract commencement in April 2027.
Suffolk County Council is testing market interest for postal delivery of nicotine replacement therapy and smoking cessation medications to improve accessibility for local residents.
PSD Scotland is engaging with the market to explore delivery solutions for a national Targeted Lung Cancer Screening Programme for smokers aged 55-74 in Scotland.
